Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
323.09
-7.50 (-2.27%)
Mar 3, 2026, 1:26 PM EST - Market open

PRAX Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
-8.552.45--
Revenue Growth (YoY)
-249.53%---
Cost of Revenue
267.12152.4186.77154.44-
Gross Profit
-267.12-143.86-84.32-154.44-
Selling, General & Admin
59.0856.3142.0559.5547.08
Research & Development
----120.26
Operating Expenses
59.0856.3142.0559.55167.33
Operating Income
-326.2-200.17-126.37-213.99-167.33
Interest & Investment Income
19.3412.343.141.962.36
EBT Excluding Unusual Items
-306.86-187.83-123.23-212.03-164.97
Merger & Restructuring Charges
----1-
Gain (Loss) on Sale of Investments
3.595.01-0.05-1-2.09
Pretax Income
-303.27-182.82-123.28-214.03-167.06
Net Income
-303.27-182.82-123.28-214.03-167.06
Net Income to Common
-303.27-182.82-123.28-214.03-167.06
Shares Outstanding (Basic)
2318733
Shares Outstanding (Diluted)
2318733
Shares Change (YoY)
25.68%171.55%114.58%8.58%374.34%
EPS (Basic)
-13.48-10.21-18.69-69.65-59.03
EPS (Diluted)
-13.48-10.21-18.69-69.65-59.03
Free Cash Flow
-249.12-131.76-111.19-185.49-125.6
Free Cash Flow Per Share
-11.07-7.36-16.86-60.36-44.38
Operating Margin
--2340.29%-5164.40%--
Profit Margin
--2137.48%-5037.88%--
Free Cash Flow Margin
--1540.48%-4543.77%--
EBITDA
-326.06-199.81-125.94-213.57-167.15
D&A For EBITDA
0.140.360.430.420.18
EBIT
-326.2-200.17-126.37-213.99-167.33
Updated Feb 19, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q